These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16648134)

  • 1. Inhibiting bacterial fatty acid synthesis.
    Zhang YM; White SW; Rock CO
    J Biol Chem; 2006 Jun; 281(26):17541-4. PubMed ID: 16648134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forty years of bacterial fatty acid synthesis.
    Rock CO; Jackowski S
    Biochem Biophys Res Commun; 2002 Apr; 292(5):1155-66. PubMed ID: 11969206
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase.
    Zhang YM; Rock CO
    J Biol Chem; 2004 Jul; 279(30):30994-1001. PubMed ID: 15133034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Product diversity and regulation of type II fatty acid synthases.
    Lu YJ; Zhang YM; Rock CO
    Biochem Cell Biol; 2004 Feb; 82(1):145-55. PubMed ID: 15052334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible route to (5R)-thiolactomycin, a naturally occurring inhibitor of fatty acid synthesis.
    McFadden JM; Frehywot GL; Townsend CA
    Org Lett; 2002 Oct; 4(22):3859-62. PubMed ID: 12599477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy.
    Ondeyka JG; Zink DL; Young K; Painter R; Kodali S; Galgoci A; Collado J; Tormo JR; Basilio A; Vicente F; Wang J; Singh SB
    J Nat Prod; 2006 Mar; 69(3):377-80. PubMed ID: 16562839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.
    Buurman ET; Andrews B; Gao N; Hu J; Keating TA; Lahiri S; Otterbein LR; Patten AD; Stokes SS; Shapiro AB
    J Biol Chem; 2011 Nov; 286(47):40734-42. PubMed ID: 21984832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural biology of type II fatty acid biosynthesis.
    White SW; Zheng J; Zhang YM; Rock
    Annu Rev Biochem; 2005; 74():791-831. PubMed ID: 15952903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial targets in fatty acid biosynthesis.
    Wright HT; Reynolds KA
    Curr Opin Microbiol; 2007 Oct; 10(5):447-53. PubMed ID: 17707686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II.
    Marrakchi H; Ducasse S; Labesse G; Montrozier H; Margeat E; Emorine L; Charpentier X; Daffé M; Quémard AK
    Microbiology (Reading); 2002 Apr; 148(Pt 4):951-960. PubMed ID: 11932442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
    Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthetic origins of the natural product, thiolactomycin: a unique and selective inhibitor of type II dissociated fatty acid synthases.
    Brown MS; Akopiants K; Resceck DM; McArthur HA; McCormick E; Reynolds KA
    J Am Chem Soc; 2003 Aug; 125(34):10166-7. PubMed ID: 12926927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal acetyltransferases structures, mechanisms and inhibitors: A review.
    Sharma S; Ahmed M; Akhter Y
    Int J Biol Macromol; 2020 Aug; 157():626-640. PubMed ID: 31786301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis.
    Kremer L; Dover LG; Carrère S; Nampoothiri KM; Lesjean S; Brown AK; Brennan PJ; Minnikin DE; Locht C; Besra GS
    Biochem J; 2002 Jun; 364(Pt 2):423-30. PubMed ID: 12023885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling.
    Pérez-Castillo Y; Froeyen M; Cabrera-Pérez MA; Nowé A
    J Comput Aided Mol Des; 2011 Apr; 25(4):371-93. PubMed ID: 21516317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii.
    Mazumdar J; H Wilson E; Masek K; A Hunter C; Striepen B
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13192-7. PubMed ID: 16920791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2004 Jan; 14(2):373-6. PubMed ID: 14698162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.